biospaceDecember 20, 2017
Tag: Bristol-Myers Squibb , performance
Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the fourth quarter of 2017 on Monday, February 5, 2018. During a conference call at 8:00 a.m. ET on February 5th company executives will review financial information and will address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 866-548-4713 or international 323-794-2093, confirmation code: 4392051. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 11:00 a.m. ET on February 5, 2018 through 11:00 a.m. ET on February 19, 2018. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820 confirmation code: 4392051.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: